Europe Smart Insulin Pens Market Analysis (2017-2023)

  • ID: 4470054
  • Report
  • Region: Europe
  • 85 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Companion Medical Inc.
  • DIAMESCO
  • Digital Medics
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Insulet Corporation
  • MORE
The Europe Smart Insulin Pen market is expected to witness market growth of 10.4% CAGR during the forecast period (2017 - 2023). Smart insulin pens are used in delivering insulin externally, and as a result, offering better diabetes management system. Insulin pens have gained popularity in the recent years. The demand is due to rapidly rising number of diabetic patients, and cost-effectiveness of the smart insulin pens. In addition, the simple functioning and accurate delivery of appropriate dosing adds to the demand. Nevertheless, some limitations prevail that limit the market growth, such as such as two types of insulin cannot be mixed in an insulin pen, therefore, leading more number of injections.

Diabetes is a major health condition that is rapidly growing among the world population; therefore, the adoption of smart insulin pens is vital for a safe and effective administration of insulin to people suffering from Diabetes. The major factors that drive the growth of the market include growing diabetic population, lower cost of insulin pumps, and painless injections. The other benefit of the device is that, it can be easily used by people with visual or motor skills impairments, which adds to the market growth. Additionally, demand for personalized or patient centric devices and need for limiting needle stick injury are the factors that add to the market expansion during the forecast period. The blood sugar control is the most challenging aspect nevertheless and security concern is still a restraining factor for the market growth.

Based on type, the market report segments the market into First Generation Pens and Second Generation Pens. Second Generation Pens further sub segmented into Bluetooth-Enabled and USB Connected. The End User covered under the report includes Hospitals & Clinics, Ambulatory Surgical Centers, and Home Care Settings. Based on usability, the market is segmented into prefilled insulin pens and reusable insulin pen. The report also covers country wise segmentation of Smart Insulin Pen market. The countries included in the report are Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the Europe Smart Insulin Pen Market. Key companies profiled in the report include Companion Medical Inc, Digital Medics Ptd Ltd, Eli Lilly and Company, Novo Nordisk A/S, DIAMESCO, F. Hoffmann-La Roche AG, Insulet Corporation, CardioComm Solutions, Inc., Emperra GmbH E-Health Technologies, and Jiangsu Delfu medical device Co.,Ltd.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Companion Medical Inc.
  • DIAMESCO
  • Digital Medics
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Insulet Corporation
  • MORE
1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Smart Insulin Pen Market, by Type
1.4.2 Europe Smart Insulin Pen Market, by Usability
1.4.3 Europe Smart Insulin Pen Market, by End User
1.4.4 Europe Smart Insulin Pen Market, by Country
1.5 Methodology for the research

2. Market Overview
2.1 Introduction
2.2 Drivers, Restraints and Opportunities
2.2.1 Market Drivers
2.2.2 Market Restraints

3. Europe Smart Insulin Pen Market
3.1 Europe Smart Insulin Pen Market by Product
3.1.1 Europe Second Generation Smart Insulin Pen by Country
3.1.2 Europe Second Generation Smart Insulin Pen by Type
3.1.2.1 Europe Bluetooth-Enabled Smart Insulin Pen Market by Country
3.1.2.2 Europe USB Connected Smart Insulin Pen Market by Country
3.1.3 Europe First Generation Smart Insulin Pen by Country

4. Europe Smart Insulin Pen Market by Usability
4.1 Introduction
4.1.1 Europe Reusable Smart Insulin Pen by Usability Market by Country
4.1.2 Europe Prefilled Smart Insulin Pen by Usability Market by Country

5. Europe Smart Insulin Pen Market by End User
5.1 Introduction
5.1.1 Europe Hospitals & Clinics Smart Insulin Pen Market by Country
5.1.2 Europe Ambulatory Surgical Centers Smart Insulin Pen Market by Country
5.1.3 Europe Home Care Settings Smart Insulin Pen Market by Country

6. Europe Smart Insulin Pen Market by Country
6.1 Germany Smart Insulin Pen Market
6.1.1 Germany Smart Insulin Pen Market by Product
6.1.1.1 Germany Second Generation Smart Insulin Pen by Type
6.1.2 Germany Smart Insulin Pen Market by Usability
6.1.3 Germany Smart Insulin Pen Market by End User
6.2 UK Smart Insulin Pen Market
6.2.1 UK Smart Insulin Pen Market by Product
6.2.1.1 UK Second Generation Smart Insulin Pen by Type
6.2.2 UK Smart Insulin Pen Market by Usability
6.2.3 UK Smart Insulin Pen Market by End User
6.3 France Smart Insulin Pen Market
6.3.1 France Smart Insulin Pen Market by Product
6.3.1.1 France Second Generation Smart Insulin Pen by Type
6.3.2 France Smart Insulin Pen Market by Usability
6.3.3 France Smart Insulin Pen Market by End User
6.4 Russia Smart Insulin Pen Market
6.4.1 Russia Smart Insulin Pen Market by Product
6.4.1.1 Russia Second Generation Smart Insulin Pen by Type
6.4.2 Russia Smart Insulin Pen Market by Usability
6.4.3 Russia Smart Insulin Pen Market by End User
6.5 Spain Smart Insulin Pen Market
6.5.1 Spain Smart Insulin Pen Market by Product
6.5.1.1 Spain Second Generation Smart Insulin Pen by Type
6.5.2 Spain Smart Insulin Pen Market by Usability
6.5.3 Spain Smart Insulin Pen Market by End User
6.6 Italy Smart Insulin Pen Market
6.6.1 Italy Smart Insulin Pen Market by Product
6.6.1.1 Italy Second Generation Smart Insulin Pen by Type
6.6.2 Italy Smart Insulin Pen Market by Usability
6.6.3 Italy Smart Insulin Pen Market by End User
6.7 Rest of Europe Smart Insulin Pen Market
6.7.1 Rest of Europe Smart Insulin Pen Market by Product
6.7.1.1 Rest of Europe Second Generation Smart Insulin Pen by Type
6.7.2 Rest of Europe Smart Insulin Pen Market by Usability
6.7.3 Rest of Europe Smart Insulin Pen Market by End User

7. Company Profiles
7.1 Eli Lilly and Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 F. Hoffmann-La Roche Ltd
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Companion Medical Inc.
7.3.1 Company Overview
7.4 Digital Medics
7.4.1 Company Overview
7.5 Novo Nordisk A/S
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 DIAMESCO
7.6.1 Company Overview
7.7 Insulet Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 CardioComm Solutions, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Emperra GmbH E-Health Technologies
7.9.1 Company Overview
7.1 Jiangsu Delfu medical device Co.,Ltd
7.10.1 Company Overview
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Companion Medical Inc.
  • Digital Medics
  • Novo Nordisk A/S
  • DIAMESCO
  • Insulet Corporation
  • CardioComm Solutions, Inc.
  • Emperra GmbH E-Health Technologies
  • Jiangsu Delfu medical device Co.,Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll